January is cervical cancer awareness month – a time to celebrate survivors, remember those we’ve lost, and encourage progress toward cervical cancer elimination.
Cervical cancer is a disease of inequity. Roughly 110,000 women are diagnosed annually, with a majority succumbing to the disease in low- and middle-income countries. Women living with HIV are up to six times more likely to develop cervical cancer.
Since 2018, PEPFAR has conducted over 7.4 million cervical cancer screenings for women living with HIV and conducted more than 302,000 treatments for precancerous lesions through the Go Further partnership.
In September 2022, the Bush Institute’s Crystal Cazier visited Kenya to meet with Go Further beneficiaries. One woman, Caroline, first tested positive for HIV in 2013. Because of PEPFAR, she was able to start antiretroviral medication and give birth to two HIV-negative children. Caroline now supports other women living with HIV by sharing her story with them and providing support. “Life is good,” she said.
Because of PEPFAR, the lives of millions of women like Caroline have been saved. Her story represents the hope and possibilities that come with treating HIV.
Kind regards,
Igor Khrestin
The Bradford M. Freeman Managing Director of Global Policy
George W. Bush Institute